Literature DB >> 6973604

Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.

A Granelli-Piperno, J D Vassalli, E Reich.   

Abstract

Mouse T cell growth factor was purified from the serum-free conditioned medium of lectin-stimulated spleen cells. A 3,000-fold purification was achieved with a final yield of 12%. The purified protein, with an apparent Mr of 23,000 by sodium dodecyl sulfate polyacrylamide gel electrophoresis, was active at concentrations of 4 x 10(-11) M, both in the T cell growth factor and T cell replacing factor assays. In addition, purified T cell growth factor alone was mitogenic for spleen cells from both nude and normal mice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973604      PMCID: PMC2186437          DOI: 10.1084/jem.154.2.422

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes.

Authors:  J Watson; L A Aarden; J Shaw; V Paetkau
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A.

Authors:  J Watson; L A Aarden; I Lefkovits
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

5.  Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.

Authors:  R R Rich; C W Pierce
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

6.  Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s).

Authors:  D W Talmage; J A Woolnough; H Hemmingsen; L Lopez; K J Lafferty
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.

Authors:  W C Greene; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  Physicochemical characterization of lymphocyte-activating factor (LAF).

Authors:  S B Mizel
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

9.  Macrophage plasminogen activator: induction by products of activated lymphoid cells.

Authors:  J D Vassalli; E Reich
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  16 in total

1.  IL-2-like activity in lymph fluid following in vivo antigen challenge.

Authors:  R Bujdoso; P Young; J Hopkins; I McConnell
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

2.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

3.  In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.

Authors:  S Makonkawkeyoon; W Kasinrerk
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.

Authors:  K Welte; C Y Wang; R Mertelsmann; S Venuta; S P Feldman; M A Moore
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

5.  Identification of a 24-kDa cytokine that is required for development of cytolytic T lymphocytes.

Authors:  C Cernetti; R M Steinman; A Granelli-Piperno
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report.

Authors:  J Bubeník; P Perlmann; M Indrová; J Símová; T Jandlová; J Neuwirt
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.

Authors:  A S Stern; Y C Pan; D L Urdal; D Y Mochizuki; S DeChiara; R Blacher; J Wideman; S Gillis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Tumour inhibitory effects of TCGF/IL-2/-containing preparations.

Authors:  J Bubeník; M Indrová; P Perlmann; K Berzins; O Mach; J Kraml; A Toulcová
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production.

Authors:  V Colizzi; J Ferluga; F Garreau; M Malkovsky; G L Asherson
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

10.  Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation.

Authors:  J M Austyn; R M Steinman; D E Weinstein; A Granelli-Piperno; M A Palladino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.